Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/30/2025

Evaluation of Postmenopausal Bleeding

Initial Diagnostic Approach

  • The American College of Radiology recommends transvaginal ultrasound (TVUS) as the first-line imaging test for women with postmenopausal bleeding to measure endometrial thickness and identify structural abnormalities of the uterus, endometrium, and ovaries 1, 2
  • An endometrial thickness of ≤4 mm on TVUS has a negative predictive value for cancer of nearly 100% 1, 2
  • If endometrial thickness is ≥5 mm, endometrial tissue sampling is indicated 1, 2
  • Office endometrial biopsy is the standard method for obtaining tissue for histological assessment, with a false-negative rate of approximately 10% 1

Follow-up Evaluation

  • If office endometrial biopsy is negative but bleeding persists, or if the biopsy is non-diagnostic, a fractional dilation and curettage (D&C) under anesthesia should be performed 1
  • Hysteroscopy may be helpful in evaluating the endometrium for lesions such as polyps in patients with persistent or recurrent undiagnosed bleeding 1
  • MRI can be considered if TVUS cannot adequately evaluate the endometrium due to patient factors or pathology, such as fibroids or adenomyosis 1

Why Pap Smear Is Not Indicated

  • The American Journal of Obstetrics and Gynecology states that Pap smear is designed to screen for cervical cancer, not endometrial cancer or other causes of postmenopausal bleeding 3
  • Cervical cancer screening guidelines recommend Pap tests every 3-5 years depending on age and HPV co-testing, but not specifically for the evaluation of postmenopausal bleeding 4
  • The primary concern with postmenopausal bleeding is endometrial cancer, which is not reliably detected by Pap smear 3, 5, 1

Important Considerations

  • In postmenopausal patients with abnormal uterine bleeding, even in the presence of fibroids, uterine sarcoma and endometrial cancer must be ruled out 1
  • The risk of unexpected uterine sarcoma is higher in older patients, up to 10.1 per 1,000 in patients 75-79 years of age 1
  • Postmenopausal women taking selective estrogen receptor modulators (SERMs) like tamoxifen should be advised to report any vaginal spotting or bleeding, as these drugs slightly increase the risk of endometrial cancer 4

Clinical Pitfalls to Avoid

  • Relying solely on Pap smear for evaluation of postmenopausal bleeding may miss endometrial pathology 3, 1
  • Using endometrial thickness cutoffs higher than 4 mm may miss cases of endometrial cancer 2, 1
  • Failing to pursue further evaluation when initial tests are negative but bleeding persists 1

Evaluation of Postmenopausal Bleeding

Diagnostic Approach

  • The National Comprehensive Cancer Network recommends that if office endometrial biopsy is negative but bleeding persists, or if the biopsy is non-diagnostic, a fractional dilation and curettage (D&C) under anesthesia should be performed 6
  • The National Comprehensive Cancer Network suggests that in patients with extrauterine disease, a serum CA-125 assay may be helpful in monitoring clinical response, though it has limitations 6

Diagnostic Tools

  • Hysteroscopy should be used as the final step in the diagnostic pathway for women with postmenopausal bleeding, especially when structural abnormalities are suspected 7
  • Saline infusion sonography can be used to distinguish between focal and diffuse pathology 7

Etiologies of Postmenopausal Vaginal Bleeding

Malignant and Benign Etiologies

  • Endometrial cancer is the most serious etiology and must be excluded first, though most postmenopausal bleeding has a benign cause, according to the American College of Radiology 8
  • Ovarian cancer may present with bleeding, particularly hormone-producing ovarian tumors, as reported by the American College of Radiology 9
  • Endometrial polyps are common structural causes that can be visualized on transvaginal ultrasound or hysteroscopy, as noted by the American College of Radiology 8
  • Endometrial hyperplasia (with or without polyps) represents a precursor to endometrial cancer and requires tissue diagnosis, according to the American College of Radiology 8
  • Cervical stenosis with hematometra can cause bleeding when the obstruction releases, as reported by the American College of Radiology 9, 10
  • Chronic pelvic inflammatory disease with hydrosalpinx or pyosalpinx may contribute to bleeding, as noted by the American College of Radiology 9, 11

REFERENCES

1

Diagnostic Approach for Postmenopausal Bleeding [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

acr appropriateness criteria® abnormal uterine bleeding. [LINK]

Journal of the American College of Radiology, 2020

6

uterine neoplasms, version 1.2018, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2018

8

acr appropriateness criteria® abnormal uterine bleeding. [LINK]

Journal of the American College of Radiology, 2020